141 related articles for article (PubMed ID: 4540495)
21. [Physical-chemical properties and antitrichomonal effect of 2-, 4-, and 5-nitroimidazoles].
Sunjić V; Kajfez F; Kolbah D; Blazević N
Pharmazie; 1972 Mar; 27(3):131-8. PubMed ID: 4558978
[No Abstract] [Full Text] [Related]
22. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
[TBL] [Abstract][Full Text] [Related]
23. [Effect of tynidazole on Trichomonas vaginalis in vitro].
Savoia D; Martinetto P; Pugliese A
G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(1):32-8. PubMed ID: 4119147
[No Abstract] [Full Text] [Related]
24. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
25. Antitrichomonal strains of Bacillus thuringiensis.
Kondo S; Mizuki E; Akao T; Ohba M
Parasitol Res; 2002 Dec; 88(12):1090-2. PubMed ID: 12444461
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of the effectiveness of antitrichomonal agents in limited Trichomonas vaginitis].
Kurnatowska A
Wiad Parazytol; 1979; 25(4):417-25. PubMed ID: 316235
[No Abstract] [Full Text] [Related]
27. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
Schwebke JR; Barrientes FJ
Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
[TBL] [Abstract][Full Text] [Related]
28. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
[TBL] [Abstract][Full Text] [Related]
29. New chemotherapeutic nitroheterocycles active against 5-nitroimidazole-resistant strains of trichomonads.
Meingassner JG; Nesvadba H; Mieth H
Arzneimittelforschung; 1981; 31(1):6-8. PubMed ID: 6971111
[TBL] [Abstract][Full Text] [Related]
30. Arsenical pessaries in the successful elimination of metronidazole-resistant Trichomonas vaginalis.
Watson PG; Pattman RS
Int J STD AIDS; 1996 Jul; 7(4):296-7. PubMed ID: 8876365
[No Abstract] [Full Text] [Related]
31. [Electron microscopic study on the morphological changes of trichomonas vaginalis treated with current medicaments].
Arai H
Nihon Sanka Fujinka Gakkai Zasshi; 1972 Jan; 24(1):39-47. PubMed ID: 4536872
[No Abstract] [Full Text] [Related]
32. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
Sobel JD; Nyirjesy P; Brown W
Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
[TBL] [Abstract][Full Text] [Related]
33. 20S Proteasome as a Drug Target in Trichomonas vaginalis.
O'Donoghue AJ; Bibo-Verdugo B; Miyamoto Y; Wang SC; Yang JZ; Zuill DE; Matsuka S; Jiang Z; Almaliti J; Caffrey CR; Gerwick WH; Eckmann L
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451503
[TBL] [Abstract][Full Text] [Related]
34. [In vitro effect of secnidazole benzoate on Trichomonas vaginalis].
Zhang XX; Zheng SS; Zhu MM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Apr; 27(2):111-4. PubMed ID: 19856497
[TBL] [Abstract][Full Text] [Related]
35. [Microbiological evaluation of the effectiveness of gynalgin in the treatment of vaginitis].
Sikorski R; Hencner Z; Gliński Z; Wawrzkiewicz K; Radomański T; Milart P; Paszkowski T; Skrzypczak W; Sławiński P; Maruszak E
Wiad Lek; 1992 Apr; 45(7-8):263-9. PubMed ID: 1462586
[TBL] [Abstract][Full Text] [Related]
36. Resistance of Trichomonas vaginalis infections to metronidazole in Auckland sexual health clinics: report of two cases.
Lo M; Reid M; Brokenshire M
N Z Med J; 2002 Aug; 115(1160):U147. PubMed ID: 12362204
[No Abstract] [Full Text] [Related]
37. Distribution of genotypes in relation to metronidazole susceptibility patterns in Trichomonas vaginalis isolated from South African pregnant women.
Mabaso N; Abbai N
Parasitol Res; 2021 Jun; 120(6):2233-2241. PubMed ID: 34002261
[TBL] [Abstract][Full Text] [Related]
38. [In vitro effect of metronidazole ester on Trichomonas vaginalis and Entamoeba histolytica].
He Y; Tao X; Guan L; Lian W
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(1):32-4. PubMed ID: 7788891
[TBL] [Abstract][Full Text] [Related]
39. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.
Meri T; Jokiranta TS; Suhonen L; Meri S
J Clin Microbiol; 2000 Feb; 38(2):763-7. PubMed ID: 10655382
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.
Pérez S; Fernández-Verdugo A; Pérez F; Vázquez F
Sex Transm Dis; 2001 Feb; 28(2):115-6. PubMed ID: 11234785
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
